Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Orthopediatrics (KIDS) over the last 10 years, with Q3 2025 value amounting to -$27.7 million.

  • Orthopediatrics' Net Cash Flow fell 22901.59% to -$27.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$34.1 million, marking a year-over-year decrease of 18608.66%. This contributed to the annual value of $12.9 million for FY2024, which is 4106.78% down from last year.
  • According to the latest figures from Q3 2025, Orthopediatrics' Net Cash Flow is -$27.7 million, which was down 22901.59% from $10.8 million recorded in Q2 2025.
  • In the past 5 years, Orthopediatrics' Net Cash Flow ranged from a high of $25.8 million in Q1 2023 and a low of -$27.7 million during Q3 2025
  • Over the past 5 years, Orthopediatrics' median Net Cash Flow value was -$1.7 million (recorded in 2022), while the average stood at -$629000.0.
  • Its Net Cash Flow has fluctuated over the past 5 years, first plummeted by 166857.31% in 2022, then soared by 208201.22% in 2024.
  • Quarter analysis of 5 years shows Orthopediatrics' Net Cash Flow stood at $1.7 million in 2021, then tumbled by 1668.57% to -$26.6 million in 2022, then surged by 174.3% to $19.8 million in 2023, then tumbled by 135.11% to -$6.9 million in 2024, then plummeted by 299.15% to -$27.7 million in 2025.
  • Its Net Cash Flow stands at -$27.7 million for Q3 2025, versus $10.8 million for Q2 2025 and -$10.3 million for Q1 2025.